Literature DB >> 19963358

An interstitial hypothesis for breast cancer related lymphoedema.

David O Bates1.   

Abstract

Breast cancer related lymphoedema (BCRL), the chronically swollen arm of patients that have been treated for breast cancer, is no longer considered to be a result of lymphatic obstruction as recent studies have identified failing peripheral lymphatic function as a principal contributing factor. The aetiology and pathophysiology that results in this lymphatic failure is not clearly understood, but it can occur with minimal or even in some cases no damage to the axillary lymph nodes, and evidence suggests that some patients are pre-disposed to develop the disease, and have poor lymphatic function in their non-affected arms. It has been shown that interstitial forces such as hydrostatic pressure, and interstitial fluid velocity, can regulate both lymph flow, and lymph formation, and there is good evidence that interstitial forces are dysregulated in lymphoedema patients. Here I outline a hypothesis for how dysregulation of interstitial parameters could contribute to the generation of breast cancer related lymphoedema, by combining disparate strands of current evidence on the molecular and physiological control of interstitial and lymph flows. One mechanism by which lymphoedema could be generated is that a reduction in interstitial velocity results in increased VEGF-C production, which in low flow conditions, instead of acting on the lymphatics to increase pumping and lymphangiogenesis, acts on vasculature to increase fluid filtration. The resulting increase in interstitial pressure restores flow, but at the expense of increased volume and hence oedema. The evidence supporting the hypothesis and possible tests of it are presented and discussed.
Copyright © 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Year:  2009        PMID: 19963358      PMCID: PMC2923079          DOI: 10.1016/j.pathophys.2009.10.006

Source DB:  PubMed          Journal:  Pathophysiology        ISSN: 0928-4680


  34 in total

1.  An easy method for diagnosis of lymphedema.

Authors:  T B Richards; M McBiles; P S Collins
Journal:  Ann Vasc Surg       Date:  1990-05       Impact factor: 1.466

2.  Secondary lymphedema in the mouse tail: Lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9.

Authors:  Joseph M Rutkowski; Monica Moya; Jimmy Johannes; Jeremy Goldman; Melody A Swartz
Journal:  Microvasc Res       Date:  2006-07-28       Impact factor: 3.514

3.  Influence of venous pressure on plasma-lymph transport in the dog's paw: convective and dissipative mechanisms.

Authors:  E M Renkin; W L Joyner; C H Sloop; P D Watson
Journal:  Microvasc Res       Date:  1977-09       Impact factor: 3.514

4.  Regional differences in capillary density of the normal human dermis.

Authors:  K A Pasyk; S V Thomas; C A Hassett; G W Cherry; R Faller
Journal:  Plast Reconstr Surg       Date:  1989-06       Impact factor: 4.730

5.  Direct measurement of interstitial convection and diffusion of albumin in normal and neoplastic tissues by fluorescence photobleaching.

Authors:  S R Chary; R K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

6.  Impairment of lymph drainage in subfascial compartment of forearm in breast cancer-related lymphedema.

Authors:  A W B Stanton; R H Mellor; G J Cook; W E Svensson; A M Peters; J R Levick; P S Mortimer
Journal:  Lymphat Res Biol       Date:  2003       Impact factor: 2.589

7.  Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.

Authors:  Harold J Burstein; Anthony D Elias; Hope S Rugo; Melody A Cobleigh; Antonio C Wolff; Peter D Eisenberg; Mary Lehman; Bonne J Adams; Carlo L Bello; Samuel E DePrimo; Charles M Baum; Kathy D Miller
Journal:  J Clin Oncol       Date:  2008-03-17       Impact factor: 44.544

8.  Lymphatic drainage in the muscle and subcutis of the arm after breast cancer treatment.

Authors:  Anthony W B Stanton; Stephanie Modi; Thomas M Bennett Britton; Anand D Purushotham; A Michael Peters; J Rodney Levick; Peter S Mortimer
Journal:  Breast Cancer Res Treat       Date:  2008-12-04       Impact factor: 4.872

9.  Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer.

Authors:  Kathy Miller; Molin Wang; Julie Gralow; Maura Dickler; Melody Cobleigh; Edith A Perez; Tamara Shenkier; David Cella; Nancy E Davidson
Journal:  N Engl J Med       Date:  2007-12-27       Impact factor: 91.245

10.  A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.

Authors:  V Joukov; K Pajusola; A Kaipainen; D Chilov; I Lahtinen; E Kukk; O Saksela; N Kalkkinen; K Alitalo
Journal:  EMBO J       Date:  1996-01-15       Impact factor: 11.598

View more
  8 in total

1.  Functional recovery of fluid drainage precedes lymphangiogenesis in acute murine foreleg lymphedema.

Authors:  Uziel Mendez; Emily M Brown; Emily L Ongstad; Justin R Slis; Jeremy Goldman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

Review 2.  Bridging the divide between pathogenesis and detection in lymphedema.

Authors:  J Brandon Dixon; Michael J Weiler
Journal:  Semin Cell Dev Biol       Date:  2014-12-26       Impact factor: 7.727

3.  Fibrosis worsens chronic lymphedema in rodent tissues.

Authors:  Laura L Lynch; Uziel Mendez; Anna B Waller; Amani A Gillette; Roger J Guillory; Jeremy Goldman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-03-13       Impact factor: 4.733

4.  Increased hyaluronan expression at distinct time points in acute lymphedema.

Authors:  Melissa A Roberts; Uziel Mendez; Ryan J Gilbert; Alexander P Keim; Jeremy Goldman
Journal:  Lymphat Res Biol       Date:  2012-09       Impact factor: 2.589

5.  Engineering the Lymphatic System.

Authors:  Matthew E Nipper; J Brandon Dixon
Journal:  Cardiovasc Eng Technol       Date:  2011-07-28       Impact factor: 2.495

6.  A chronic and latent lymphatic insufficiency follows recovery from acute lymphedema in the rat foreleg.

Authors:  Uziel Mendez; Emily M Stroup; Laura L Lynch; Anna B Waller; Jeremy Goldman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-31       Impact factor: 4.733

7.  Higher vascular endothelial growth factor-C concentration in plasma is associated with increased forearm capillary filtration capacity in breast cancer-related lymphedema.

Authors:  Mads Radmer Jensen; Lene Simonsen; Tonny Karlsmark; Charlotte Lanng; Jens Bülow
Journal:  Physiol Rep       Date:  2015-06

Review 8.  Lymphedema in survivors of breast cancer.

Authors:  Lin He; Huili Qu; Qian Wu; Yuhua Song
Journal:  Oncol Lett       Date:  2020-01-16       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.